Data / Form D filings / XTRESSE, LLC
XTRESSE, LLC: Form D filing
XTRESSE, LLC, a pharmaceuticals company in Orlando, FL, filed a Form D with the SEC in 2025. The latest, on November 24, 2025, reports $2.7 million sold of a $10 million offering to 30 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3801 AVALON PARK E. BLVD, SUITE 350A, Orlando, FL, 32828
- Phone
- (000) 000-0000
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Florida
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2097458
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | New notice | $10,000,000 | $2,691,250 | $7,308,750 | 30 | Oct 24, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Matt Leavitt | Director |
Other pharmaceuticals companies in Florida that filed recently
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Nov 24, 2025 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what XTRESSE, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.